| Trial registration number
|
NCT04858633 |
Full text link
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04858633
|
First author
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Deba Prasad Dhibar, MD
|
Contact
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
dhibar.dp@pgimer.edu.in
|
Registration date
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-04-26
|
Recruitment status
Last imported at : June 4, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Prevention
|
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
gender: male/female
age of ≥18 years
asymptomatic individual with direct contact with laboratory confirmed covid-19 cases
|
Exclusion criteria
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
1. symptomatic individual 2. health care worker 3. individual who will not give consent for
hcq prophylaxis 4. contraindication for hcq therapy 5. pregnancy 6. individual who received
covid-19 vaccine
-
|
Number of arms
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : April 1, 2024, 4 a.m.
Source : ClinicalTrials.gov
|
Post Graduate Institute of Medical Education and Research, Chandigarh
|
Inclusion age min
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
India
|
Type of patients
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Close contacts to covid patients
|
Severity scale
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : June 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
1000
|
primary outcome
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Definite COVID-19;Incidence of COVID-19;Probable COVID-19
|
Notes
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Phase 3
|
Arms
Last imported at : April 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|